The discovery has broad ranging applications in stopping viral outbreaks such as hepatitis C in humans and a number of viruses in plants and animals
Viruses are molecular thieves that take from their hosts under the cloak of darkness. But now a Virginia Tech scientist has found a way to not only track viral hijackers, but also potentially stop them from replicating.
The discovery has broad ranging applications in stopping viral outbreaks such as Hepatitis C in humans and a number of viruses in plants and animals because it applies to many viruses in the largest category of viral classes — positive-strand RNA viruses.
The findings were recently published in the Proceedings of the National Academy of Sciences.
“Even though these viruses infect very different hosts, they all replicate similarly across the board, so what we learn from one virus can potentially be translated to control viruses in agricultural production as well as human health,” said Xiaofeng Wang, an assistant professor of plant pathology, physiology, and weed science in the College of Agriculture and Life Sciences.
Wang’s findings could target any number of plant viruses. One virus Wang has studied — the cucumber mosaic virus — affects pumpkin, squash and gourds in 1,200 species in over 100 plant families.
Sprays could be developed to halt the virus on plants, saving millions of dollars in agricultural sectors.
Wang, who is a Fralin Life Science-associated faculty member, used brome mosaic virus to study how viral infections start. He found that the brome mosaic virus stimulates synthesis of host lipid cells called phosphatidylcholine at the sites where viral replication occurs, and that by inhibiting its synthesis, the viral replication stopped.
Wang also collaborated with researchers to study how human viruses like Hepatitis C virus and poliovirus regulate host lipid synthesis and found that viral replication behaved in the same way as using plant viruses. The ramifications for human health mean that developing a drug delivery system to combat the Hepatitis C virus would be much more nimble in treating viral outbreaks than slow-moving vaccines, and could play a crucial role in halting the debilitating infection which affects 3.5 million people in the U.S. according to the Centers for Disease Control.
Viruses can’t replicate by themselves. They are essentially thieves that break into cells and multiply by hijacking the machinery of the host cells and proliferating and remodeling lipid-containing membranes such as phosphatidylcholine — one the most prominent lipids in host membranes. Wang and his collaborators were able to see where exactly the virus replications started and how they managed their hosts to meet their needs. Based on the finding of Wang and his collaborators, new ways can be developed to stop phosphatidylcholine synthesis for viral replication, but leave the host undamaged.
“The better we understand the mechanisms of a biological process, be it virus replication or cell division, the better are our options to rationally design tools that can control it,” said George Belov, a collaborator of Wang’s and an assistant professor of virology at the University of Maryland. “In the case of viral replication it may provide us with novel ways to control infection without causing host toxicity and a generation of viral-resistant mutants.”
The Latest on: Stopping virus replication
via Google News
The Latest on: Stopping virus replication
- Nationality shapes views of a global war’s burdenson August 15, 2019 at 7:13 am
Other proteins might protect bacteria from toxins that the bacteria use to kill viruses. Small proteins could have applications ... The likelihood that traffic would come to a complete stop was best ...
- Live mitochondria seen in unprecedented detail: photobleaching in STED microscopy overcomeon August 8, 2019 at 10:18 am
Viruses and individual proteins are much smaller ... around the small fluorescing structure again, suppose you somehow stop light being sent to the detector from as large an area as possible ...
- Transgene Provides an Update after the Interim Futility Analysis of the PHOCUS Study of Pexa-Vec in Liver Canceron August 7, 2019 at 8:35 am
The recommendation to stop the PHOCUS trial is not caused ... These carry a double deletion TK-RR-, which makes their replication more selective than viruses carrying a simple TK deletion such ...
- Enanta Pharmaceuticals' (ENTA) CEO Jay Luly on Q3 2019 Results - Earnings Call Transcripton August 6, 2019 at 7:34 pm
I’ll begin my review of our clinical development programs with our most advanced program, EDP-938 for respiratory syncytial virus known ... targets the viral replication process of RSV and ...
- Study explores blood-brain barrier leakage in CNS infectionson August 6, 2019 at 3:04 am
We see the blood brain barrier breakdown happening in the last 6 to 7 days after infection, after seeing evidence that the virus is being ... you need to stop the replication of the pathogen ...
- Incomplete influenza A virus genomes occur frequently but are readily complemented during localized viral spreadon August 6, 2019 at 2:11 am
The potential for complementation of IVGs in vivo was furthermore evidenced by the replication in guinea pigs of Pan/99-M.STOP virus, which requires coinfection for productive infection. Importantly, ...
- Viral HIV vaccine gives durable protection against 'death star' strainon July 24, 2019 at 12:56 pm
The tough-to-stop research strain is SIVmac239 ... Primates are the only animals, other than humans, that support replication of these viruses. There's much more work to be done, notes first author ...
- Enanta Pharmaceuticals, Inc. (ENTA) Q2 2019 Earnings Call Transcripton May 7, 2019 at 6:25 pm
I'll begin my review of our clinical development programs with our most advanced program: EDP-938 for Respiratory Syncytial Virus, known as RSV ... because EDP-938 directly targets the viral ...
- Compound made inside human body stops viruses from replicatingon June 20, 2018 at 10:13 am
"We knew viperin had broad antiviral effects through some sort of enzymatic activity, but other antivirals use a different method to stop ... in a group of viruses called flaviviruses. Then they ...
- Statins Stop Hepatitis C Virus From Replicatingon July 8, 2006 at 5:00 pm
This combined therapy was more effective against HCV RNA replication than interferon alone and ... John Wiley & Sons, Inc.. "Statins Stop Hepatitis C Virus From Replicating." ScienceDaily.
via Bing News